ERBB2 and ductal breast carcinoma in situ: Using controlled patient groups with ER+, HER2- luminal IDC, with and without LN metastasis, we demonstrate that LNs from patients with IDC display extensive remodeling of HEVs compared with patients with non-invasive DCIS or cancer-free ODs.